Back to Search
VALSAMO ANAGNOSTOU, MD-PHD
MD-PHD
Medical Oncology Physician
NPI: 1821314030Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
D76717(MD)
Education
OTHER
Class of 2005
Research & Publications (9)
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.
PMID 19553991·Nature·2009
7-preclinical
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
PMID 19509151·Clin Cancer Res·2009
8-other
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
PMID 19064983·J Clin Oncol·2009
8-other
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
PMID 18521745·Breast Cancer Res Treat·2009
8-other
Right sited renal cell carcinoma metastasizing to the contralateral ovary: case report and review of the literature.
PMID 18493874·Pathol Oncol Res·2009
5-case
Ontogeny of intrinsic innervation in the human thymus and spleen.
PMID 17438351·J Histochem Cytochem·2007
8-other
Using statins to reduce cardiovascular risk after carotid endarterectomy.
PMID 16530653·Evid Based Cardiovasc Med·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1650 ORLEANS STREET, CRB 186
BALTIMORE, MD 21231 - Phone
- (410) 955-8893
Quick Facts
- NPI
- 1821314030
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 9
Are you this provider?
Claim Your Profile